|
|
Effects of overweight and obesity on standardized treatment and pulmonary function in children with bronchial asthma |
LI Jingpeng1 LIU Chuanhe2▲ WANG Mengmeng1 WEI Hong1 WANG Genxiang1 |
1.Department of Pediatrics, Zhanlanlu Hospital in Xicheng District, Beijing 100044, China;
2.Department of Asthma Center and Lung Function Laboratory, Children’s Hospital, Capital Institute of Pediatrics, Beijing 100020, China
|
|
|
Abstract Objective To investigate the effects of overweight and obesity on standardized treatment and pulmonary function in children with bronchial asthma (“asthma” for short). Methods A total of 120 children with acute asthma attack from January 2020 to January 2021 in the Department of Pediatric Outpatient, Zhanlanlu Hospital in Xicheng District, Beijing were selected as the research objects. According to the body mass index percentile numerical method, they were divided into overweight and obesity group (≥85%, 59 cases) and normal weight group (16%-<85%, 61 cases). Both groups received standardized treatment, the clinical efficacy of two groups was compared; the number of asthma attacks, emergency department visits due to asthma attacks, and lung function level were compared between two groups. Results The number of annual attacks and emergency department visits due to asthma attacks in overweight and obesity group was higher than those in normal weight group, and the score of asthma control test was lower than that in normal weight group, and the differences were statistically significant (P<0.05). The clinical effect of overweight and obesity group was worse than that of normal weight group, and the difference was statistically significant (P<0.05). After treatment, forced vital capacity (FVC), peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), FEV1/FVC, and forced expiratory flow at 50% forced vital capacity (FEF50) in normal weight group were higher than those before treatment; FVC, PEF, FEV1, and FEV1/FVC in overweight and obese group were higher than those before treatment, and the differences were statistically significant (P<0.05). There was no significant difference in FEF50 between overweight and obese groups before and after treatment (P>0.05). The improvement rates of FEV1, FEV1/FVC, PEF, and FEF50 in overweight and obese groups were lower than those in normal weight group, and the differences were statistically significant (P<0.05). Conclusion Overweight and obesity in children are associated with poor asthma control and can increase lung function impairment in children with asthma.
|
|
|
|
|
[1] Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020 [EB/OL].(2020-01-06)[2020- 04-06]. https://ginasthma.org/gina-reports/.
[2] 陈育智,赵京,刘传合.儿童支气管哮喘的诊断及治疗[M].3版.北京:人民卫生出版社,2018:97-102.
[3] 李辉,季成叶,宗心南,等.中国0-18岁儿童、青少年体块指数生长曲线[J].中华儿科杂志,2009,7(47):493- 498.
[4] 李京鹏,魏红,李学军,等.儿童支气管哮喘社区管理模式的探索[J].中华儿科杂志,2016,5(52):353-357.
[5] 中华医学会儿科学会呼吸学组.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,3(54):167- 181.
[6] 马冠生.中国儿童肥胖报告[R].北京:人民卫生出版社,2017.
[7] 黄书慧.儿童肥胖性哮喘的研究进展[J].国际儿科学杂志.2022,49(4):258-261.
[8] Lara F,Gabriele DV,Aliva D,et al. Atopy and Pulmonary Function Among Healthy-weight and Overweight/Obese Children with Asthma [J]. Pediatric Pulmonology,2020,56(1):34-41.
[9] Ceire H,Sarah EH. The impact of obesity on immune function in pediatric asthma [J]. Curr Opin Allergy Clin Immunol,2021,21(2):202-215.
[10] 蒋熠,钱俊,顾晓红,等.儿童肥胖与支气管哮喘的相关性研究[J].医学综述,2019,25(13):2530-2535.
[11] 赵红英.儿童肥胖和常见呼吸系统疾病的相关性[J].河北医药,2020,42(13):2055-2059.
[12] Zhao ZZ,Yan J G,Hu WB Shi,et al. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank [J]. J Allergy Clin Immunol,2020,145(2):537-549.
[13] 张瀚文,翁育清.肥胖型哮喘发病机制及治疗进展[J].岭南急诊医学杂志,2022,27(2):200-202.
[14] 献墨.肥胖与哮喘[J].中华临床免疫和变态反应杂志,2021,15(5):588.
[15] Xin MS,Yuan R,Meng LL,et al. Association between lipid profile and the prevalence of asthma:a meta-analysis and systemic review [J]. Curr Med Res Opin,2018,34(3):423- 433.
[16] 彭佳瑜,黄英欧,江燕,等.血脂与儿童期哮喘的相关性[J].中国当代儿科杂志,2018,20(12):456-460.
[17] 姚灵,李南方,姚晓光,等.肺泡表面活性物质相关蛋白A的研究进展[J].医学研究杂志,2019,48(12):24-27.
[18] 杨哲,宋欣,李硕,等.支气管哮喘控制患儿小气道功能状况及影响因素分析[J].中华实用儿科临床杂志,2017, 32(16):1244-1247.
[19] Emily SW,Liu JP,Molly B,et al. Standardized Rat Model Testing Effects of Inflammation and Grafting on Extraction Healing [J]. J Periodontol,2017,88(8):799-807.
[20] 徐洋海,刘甡,刘雪凤.肥胖诱发哮喘发病的作用机制研究进展[J].中国医药科学,2021,11(2):50-53.
[21] 屠兴柱.肥胖儿童哮喘临床特征及其对药物治疗反应性的研究[J].中国处方药,2022,20(1):162-164.
[22] 邓文华,陈锋.吸入性糖皮质激素联合长效β2受体激动剂治疗肥胖儿童哮喘的疗效分析[J].中国处方药,2020,18(4):72-73.
[23] Giovanni P,Giulio M,Sebastian F,et al. Gastroesophaeal reflux and asthma:when,how,and why [J]. Curr Opin Allergy Clin Immunol,2021,21(1):52-58. |
|
|
|